+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

LAMEA HPV Testing and Pap Test Market By Type, By Application, By Product, By End Use, By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

  • ID: 5354470
  • Report
  • June 2021
  • Region: Middle East, Africa
  • 100 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Abbott Laboratories
  • Arbor Vita Corporation
  • F. Hoffmann-La Roche Ltd.
  • Femasys, Inc.
  • Hologic, Inc.
  • Qiagen N.V.`
The Latin America, Middle East and Africa HPV Testing and Pap Test Market is expected to witness market growth of 34.6% CAGR during the forecast period (2021-2027).

The market of HPV testing and Pap test is expected to witness bright growth prospects with the increasing demand for technologically sophisticated diagnostic procedures for screening cervical and vaginal cancers. This aspect will also boost the adoption of these testing methods during the forecast period. In addition to this, consistent advancements in technology like the development of HPV-type 16 E7-specific human immunologic assays utilized in non-HLA2 types, Cobas system approvals, and utilization of different kinds of molecular markers in screening procedures, is expected to create new growth avenues for the HPV testing and Pap Test.

As there are many countries of Latin America and Africa that are struggling with poverty for a long time. That is why it becomes necessary to create awareness regarding the hazards of cervical cancer among women and informing them about the importance of early-detection tests and their accessibility. This has been the focus of many governments in the region to roll out any screening program. Literacy programs for education and awareness about family planning tools are becoming an essential aspect of creating awareness about this illness. It was found that these awareness and literacy programs are able to motivate women to undergo screening procedures.

The Brazil market dominated the LAMEA Immunodiagnostics Market by Country 2020, thereby, achieving a market value of $34.5 million by 2027. The Argentina market is expected to witness a CAGR of 36.4% during (2021 - 2027). Additionally, The UAE market is experiencing a CAGR of 35.3% during (2021 - 2027).

Based on Type, the market is segmented into Pap Test and HPV Testing. Based on Application, the market is segmented into Cervical Cancer Screening, and Vaginal Cancer Screening. Based on Product, the market is segmented into Consumables, Instruments, and Services. Based on End Use, the market is segmented into Hospitals & Clinics, Laboratories and Other End Users. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Hologic, Inc., Quest Diagnostics, Incorporated, Seegene, Inc., Arbor Vita Corporation, Femasys, Inc., and Qiagen N.V.

Scope of the Study

Market Segments covered in the Report:

By Type
  • Pap Test
  • HPV Testing
By Application
  • Cervical Cancer Screening,
  • Vaginal Cancer Screening
By Product
  • Consumables
  • Instruments,
  • Services
By End Use
  • Hospitals & Clinics
  • Laboratories
  • Other End Users
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Quest Diagnostics, Incorporated
  • Seegene, Inc.
  • Arbor Vita Corporation
  • Femasys, Inc.
  • Qiagen N.V.
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Arbor Vita Corporation
  • F. Hoffmann-La Roche Ltd.
  • Femasys, Inc.
  • Hologic, Inc.
  • Qiagen N.V.`
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA HPV Testing And PAP Test Market, by Type
1.4.2 LAMEA HPV Testing And PAP Test Market, by Application
1.4.3 LAMEA HPV Testing And PAP Test Market, by Product
1.4.4 LAMEA HPV Testing And PAP Test Market, by End Use
1.4.5 LAMEA HPV Testing And PAP Test Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition & Scenario:
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
2.2.3 Market Opportunity

Chapter 3. LAMEA HPV Testing And Pap Test Market by Type
3.1 LAMEA Pap Test Market by Country
3.2 LAMEA HPV Testing Market by Country

Chapter 4. LAMEA HPV Testing And Pap Test Market by Application
4.1 LAMEA Cervical Cancer Screening Market by Country
4.2 LAMEA Vaginal Cancer Screening Market by Country

Chapter 5. LAMEA HPV Testing And Pap Test Market by Product
5.1 LAMEA Consumables Market by Country
5.2 LAMEA Instruments Market by Country
5.3 LAMEA Services Market by Country

Chapter 6. LAMEA HPV Testing And Pap Test Market by Technology
6.1 LAMEA PCR Market by Country
6.2 LAMEA Immunodiagnostics Market by Country
6.3 LAMEA Other Technologies Market by Country

Chapter 7. LAMEA HPV Testing And Pap Test Market by End Use
7.1 LAMEA Hospitals & Clinics Market by Country
7.2 LAMEA Laboratories Market by Country
7.3 LAMEA Other End Uses Market by Country

Chapter 8. LAMEA HPV Testing And Pap Test Market by Country
8.1 Brazil HPV Testing And Pap Test Market
8.1.1 Brazil HPV Testing And Pap Test Market by Type
8.1.2 Brazil HPV Testing And Pap Test Market by Application
8.1.3 Brazil HPV Testing And Pap Test Market by Product
8.1.4 Brazil HPV Testing And Pap Test Market by Technology
8.1.5 Brazil HPV Testing And Pap Test Market by End Use
8.2 Argentina HPV Testing And Pap Test Market
8.2.1 Argentina HPV Testing And Pap Test Market by Type
8.2.2 Argentina HPV Testing And Pap Test Market by Application
8.2.3 Argentina HPV Testing And Pap Test Market by Product
8.2.4 Argentina HPV Testing And Pap Test Market by Technology
8.2.5 Argentina HPV Testing And Pap Test Market by End Use
8.3 UAE HPV Testing And Pap Test Market
8.3.1 UAE HPV Testing And Pap Test Market by Type
8.3.2 UAE HPV Testing And Pap Test Market by Application
8.3.3 UAE HPV Testing And Pap Test Market by Product
8.3.4 UAE HPV Testing And Pap Test Market by Technology
8.3.5 UAE HPV Testing And Pap Test Market by End Use
8.4 Saudi Arabia HPV Testing And Pap Test Market
8.4.1 Saudi Arabia HPV Testing And Pap Test Market by Type
8.4.2 Saudi Arabia HPV Testing And Pap Test Market by Application
8.4.3 Saudi Arabia HPV Testing And Pap Test Market by Product
8.4.4 Saudi Arabia HPV Testing And Pap Test Market by Technology
8.4.5 Saudi Arabia HPV Testing And Pap Test Market by End Use
8.5 South Africa HPV Testing And Pap Test Market
8.5.1 South Africa HPV Testing And Pap Test Market by Type
8.5.2 South Africa HPV Testing And Pap Test Market by Application
8.5.3 South Africa HPV Testing And Pap Test Market by Product
8.5.4 South Africa HPV Testing And Pap Test Market by Technology
8.5.5 South Africa HPV Testing And Pap Test Market by End Use
8.6 Nigeria HPV Testing And Pap Test Market
8.6.1 Nigeria HPV Testing And Pap Test Market by Type
8.6.2 Nigeria HPV Testing And Pap Test Market by Application
8.6.3 Nigeria HPV Testing And Pap Test Market by Product
8.6.4 Nigeria HPV Testing And Pap Test Market by Technology
8.6.5 Nigeria HPV Testing And Pap Test Market by End Use
8.7 Rest of LAMEA HPV Testing And Pap Test Market
8.7.1 Rest of LAMEA HPV Testing And Pap Test Market by Type
8.7.2 Rest of LAMEA HPV Testing And Pap Test Market by Application
8.7.3 Rest of LAMEA HPV Testing And Pap Test Market by Product
8.7.4 Rest of LAMEA HPV Testing And Pap Test Market by Technology
8.7.5 Rest of LAMEA HPV Testing And Pap Test Market by End Use

Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Approvals & Trials:
9.2.5.2 Product Launches and Product Expansions:
9.3 Thermo Fisher Scientific, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Becton, Dickinson and Company
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Approvals & Trials:
9.5 Hologic, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Approvals & Trials:
9.6 Quest Diagnostics, Incorporated
9.6.1 Company Overview
9.6.2 Financial Analysis
9.7 Qiagen N.V.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expense
9.8 Seegene, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Research & Development Expense
9.9 Arbor Vita Corporation
9.9.1 Company Overview
9.10. Femasys, Inc.
9.10.1 Company Overview
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Quest Diagnostics, Incorporated
  • Seegene, Inc.
  • Arbor Vita Corporation
  • Femasys, Inc.
  • Qiagen N.V.`
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll